Articles with public access mandates - Aloran MazumderLearn more
Not available anywhere: 2
Natural scaffolds in anticancer therapy and precision medicine
A Mazumder, C Cerella, M Diederich
Biotechnology advances 36 (6), 1563-1585, 2018
Mandates: Luxembourg National Research Fund
Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells
C Grandjenette, M Schnekenburger, A Gaigneaux, D Gerard, C Christov, ...
Cancer Letters 469, 468-480, 2020
Mandates: Luxembourg National Research Fund
Available somewhere: 14
Cardiac glycoside glucoevatromonoside induces cancer type-specific cell death
NFZ Schneider, C Cerella, JY Lee, A Mazumder, KR Kim, A De Carvalho, ...
Frontiers in pharmacology 9, 70, 2018
Mandates: European Commission, Luxembourg National Research Fund
Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release
A Mazumder, JY Lee, O Talhi, C Cerella, S Chateauvieux, A Gaigneaux, ...
Cancer letters 438, 197-218, 2018
Mandates: Fundação para a Ciência e a Tecnologia, Portugal, European Commission …
Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute myeloid leukemia
C Cerella, A Gaigneaux, A Mazumder, JY Lee, E Saland, F Radogna, ...
Leukemia 31 (3), 755-759, 2017
Mandates: National Institute of Health and Medical Research, France, Luxembourg …
Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia
S Song, JY Lee, L Ermolenko, A Mazumder, S Ji, H Ryu, HJ Kim, DW Kim, ...
Cell death & disease 11 (2), 109, 2020
Mandates: Luxembourg National Research Fund
Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New …
M Schnekenburger, E Goffin, JY Lee, JY Jang, A Mazumder, S Ji, ...
Journal of medicinal chemistry 60 (11), 4714-4733, 2017
Mandates: Luxembourg National Research Fund
Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells
M Lernoux, M Schnekenburger, H Losson, K Vermeulen, H Hahn, ...
Clinical Epigenetics 12, 1-26, 2020
Mandates: Luxembourg National Research Fund
HER2 activation and endocrine treatment resistance in HER2-negative breast cancer
A Mazumder, S Shiao, S Haricharan
Endocrinology 162 (10), bqab153, 2021
Mandates: US Department of Defense, US National Institutes of Health, Susan G. Komen
Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer
NB Punturi, S Seker, V Devarakonda, A Mazumder, R Kalra, CH Chen, ...
Nature communications 12 (1), 2940, 2021
Mandates: US Department of Defense, US National Institutes of Health, Cancer …
The DNA damage repair landscape in Black women with breast cancer
A Mazumder, A Jimenez, RE Ellsworth, SJ Freedland, S George, ...
Therapeutic advances in medical oncology 14, 17588359221075458, 2022
Mandates: US Department of Defense, US National Institutes of Health, Susan G. Komen
Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness
E Oropeza, S Seker, S Carrel, A Mazumder, D Lozano, A Jimenez, ...
Science Advances 9 (26), eadf2860, 2023
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome
MN Bainbridge, A Mazumder, D Ogasawara, R Abou Jamra, G Bernard, ...
Brain 145 (10), 3383-3390, 2022
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Marine polyether phycotoxin palytoxin induces apoptotic cell death via Mcl-1 and Bcl-2 downregulation
J Kim, S Ji, JY Lee, J Lorquin, B Orlikova-Boyer, C Cerella, A Mazumder, ...
Marine drugs 21 (4), 233, 2023
Mandates: Luxembourg National Research Fund
Differential impact of mutations in cell cycle checkpoint kinases on breast cancer presentation and prognosis
S Seker, NB Punturi, S Carell, AM Mazumder, N Fusco, MN Bainbridge, ...
bioRxiv, 2020.10. 29.361352, 2020
Mandates: US Department of Defense, US National Institutes of Health
Race specific differences in DNA damage repair dysregulation in breast cancer and association with outcome
A Mazumder, A Jimenez, RE Ellsworth, SJ Freedland, S George, ...
bioRxiv, 2020.10. 26.356006, 2020
Mandates: US Department of Defense, US National Institutes of Health, Susan G. Komen
Publication and funding information is determined automatically by a computer program